BIO-Europe 2026
Talk Presenting Companies (Theatre B) track
Cell and Gene Therapies: NK Bioscience Research Inc.
Tue, Nov 10, 2026 · 9:45–10:00 AM CET Koelnmesse
About this session
NK Bioscience is an early-stage company in the rapidly advancing field of cell-based medicine. We are developing a novel approach to therapies for cancer, particularly solid tumours. By engineering natural killer (NK) cells to overcome the issues of immunosuppression, we have proprietary cell lines that attack and destroy melanoma cells in the presence of clinically relevant levels of immunosuppressive factors.
Speaker
-
Founder/ CEO · NK Bioscience Research Inc.
Speaker